Third-Party Payers Strike Out in Suits Alleging Off-Label Promotion Injuries
Executive Summary
While the pharma industry has plenty of litigation headaches there is good news on one front: courts are tossing out third-party payer suits alleging companies illegally marketed their drugs for off-label use